Citadel Advisors’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,662
Closed -$15.4K 6870
2023
Q1
$15.4K Sell
3,662
-47,649
-93% -$200K ﹤0.01% 5443
2022
Q4
$308K Sell
51,311
-439,486
-90% -$2.64M ﹤0.01% 4305
2022
Q3
$2.86M Sell
490,797
-328,777
-40% -$1.91M ﹤0.01% 2389
2022
Q2
$4.89M Buy
819,574
+717,668
+704% +$4.28M ﹤0.01% 1882
2022
Q1
$476K Buy
101,906
+79,790
+361% +$373K ﹤0.01% 4500
2021
Q4
$55K Sell
22,116
-47,557
-68% -$118K ﹤0.01% 6138
2021
Q3
$205K Buy
+69,673
New +$205K ﹤0.01% 5408
2021
Q2
Sell
-211,206
Closed -$615K 7582
2021
Q1
$615K Buy
211,206
+189,165
+858% +$551K ﹤0.01% 4389
2020
Q4
$71K Buy
+22,041
New +$71K ﹤0.01% 4781
2020
Q3
Hold
0
5637
2020
Q2
Sell
-29,289
Closed -$27K 5671
2020
Q1
$27K Buy
+29,289
New +$27K ﹤0.01% 4626
2019
Q2
Hold
0
5437
2019
Q1
Sell
-74,395
Closed -$55K 5403
2018
Q4
$55K Buy
74,395
+30,126
+68% +$22.3K ﹤0.01% 4097
2018
Q3
$96K Buy
44,269
+18,489
+72% +$40.1K ﹤0.01% 3910
2018
Q2
$129K Buy
+25,780
New +$129K ﹤0.01% 3784
2018
Q1
Sell
-11,418
Closed -$31K 4749
2017
Q4
$31K Buy
+11,418
New +$31K ﹤0.01% 3722
2017
Q1
Sell
-6,696
Closed -$27K 4569
2016
Q4
$27K Buy
+6,696
New +$27K ﹤0.01% 3409
2016
Q3
Hold
0
4501
2016
Q2
Sell
-12,987
Closed -$69K 4366
2016
Q1
$69K Buy
12,987
+8,817
+211% +$46.8K ﹤0.01% 2958
2015
Q4
$51K Buy
4,170
+3,406
+446% +$41.7K ﹤0.01% 3437
2015
Q3
$11K Buy
+764
New +$11K ﹤0.01% 3880
2015
Q2
Sell
-91,302
Closed -$1.65M 4447
2015
Q1
$1.65M Buy
91,302
+16,158
+22% +$293K ﹤0.01% 1922
2014
Q4
$1.77M Buy
75,144
+73,219
+3,804% +$1.73M ﹤0.01% 1739
2014
Q3
$47K Buy
1,925
+1,715
+817% +$41.9K ﹤0.01% 3180
2014
Q2
$6K Sell
210
-61,737
-100% -$1.76M ﹤0.01% 3383
2014
Q1
$2.11M Buy
61,947
+59,687
+2,641% +$2.03M ﹤0.01% 1468
2013
Q4
$43K Buy
2,260
+1,157
+105% +$22K ﹤0.01% 2780
2013
Q3
$18K Buy
+1,103
New +$18K ﹤0.01% 2796